BellRing Brands, Inc.

BellRing Brands, Inc. (BRBR) Market Cap

BellRing Brands, Inc. has a market capitalization of $1.02B.

Price: $8.77

0.08 (0.92%)

Market Cap: 1.02B

NYSE · time unavailable

CEO: Darcy Horn Davenport

Sector: Consumer Defensive

Industry: Packaged Foods

IPO Date: 2019-10-18

Website: https://bellring.com

BellRing Brands, Inc. (BRBR) - Company Information

Market Cap: 1.02B|Sector: Consumer Defensive

Company Profile

BellRing Brands, Inc., together with its subsidiaries, provides various nutrition products in the United States and internationally. It offers ready-to-drink shake and powder protein products primarily under the Premier Protein and Dymatize brands. The company sells its products through club, food, drug, mass, eCommerce, specialty, and convenience channels. BellRing Brands, Inc. was incorporated in 2019 and is headquartered in Saint Louis, Missouri.

Analyst Sentiment

77%
Strong Buy

From 15 Active Polls

1Y Forecast: $18.75

▲ +113.8% Potential Upside

Consensus Target Metrics

Low Bound

$11

Median

$14

High Bound

$32

Average

$19

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$18.75
▲ +113.80% Upside
Low Target
$11.00
25% Risk
Median Target
$13.50
54% Mid
High Target
$32.00
265% Max
Consensus
Buy
14 / 21 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,0201,9033,1894,5077,4099,5469,7117,9127,535
Enterprise Value ($M)2,1723,0554,3095,5328,37510,47110,4958,6808,301
Price to Earnings Ratio (P/E)6.5614.0418.2418.9188.2140.6531.5727.5925.56
Price/Earnings-to-Growth Ratio (PEG)1.231.033.933.526.08
Price to Sales Ratio (P/S)0.443.185.946.9513.5316.2318.2214.2414.62
Price to Book Ratio (P/B)-2.08-3.82-6.24-9.93-23.91-37.57-66.24-38.43-30.98
Price to Free Cash Flow Ratio (P/FCF)5.47-146.42-436.8326.81192.45200.545712.54203.39109.36
Enterprise Value to Sales (EV/Sales)5.108.028.5315.3017.8119.6915.6216.11
Enterprise Value to EBITDA (EV/EBITDA)7.9564.5951.6751.70235.24105.0387.5377.4371.44
Debt to Equity Ratio4.21-2.38-2.32-2.45-3.26-3.75-5.68-4.08-3.45

BRBR Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$8.77
Intrinsic Value$56.51
Market Alignment
Undervalued by 544.3%relative to calculated intrinsic value
9.00%
Exp: 17%17%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.71B
Perpetuity TV Value$13.43B
Discounted TV (PV)$5.68B
TV Weighting %65.9%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 BELLRING BRANDS INC (BRBR) — Investment Overview

🧩 Business Model Overview

BellRing Brands operates in the health-and-performance nutrition category, selling branded protein and nutrition products (e.g., ready-to-drink shakes, powders, and bars) through grocery, mass, club, and e-commerce channels. The value chain is straightforward: BellRing develops and markets formulations, manufactures or sources products, and ships finished goods into retailer distribution networks. Revenue is primarily driven by repeat consumer purchasing of specific product formats and flavors, with retailer shelf placement and promotional execution strongly influencing volume. The practical “stickiness” comes less from contractual lock-in and more from distribution leverage, brand presence within protein use cases (fitness, weight management, meal replacement), and the consumer habituation that forms around preferred SKUs.

💰 Revenue Streams & Monetisation Model

BellRing’s monetisation is largely product sales rather than long-term subscriptions. The revenue base is a mix of:
  • Branded protein beverages and bars (typically higher volume, promotion-sensitive): throughput and distribution breadth are key.
  • Protein powders (mix-dependent): generally supports brand-led premium positioning and can carry favorable gross margin when input costs and channel execution are aligned.
Margin drivers center on:
  • Gross margin management through ingredient procurement (milk protein/whey-related inputs), packaging costs, and manufacturing efficiency.
  • Channel and mix: shifts between beverage vs. powder, retailer tiers, and e-commerce can materially affect realized pricing and trade spend.
  • Trade spend discipline: retailer allowances, marketing investment, and promotional intensity influence net revenue per unit.

🧠 Competitive Advantages & Market Positioning

BellRing’s moat is best characterized as Scale/Distribution leverage combined with Brand-led private label resistance in protein-centric occasions.
  • Scale/Distribution leverage: Broad retailer coverage and category execution create shelf momentum. Competitors with weaker distribution footing face higher costs to win placements and defend velocity.
  • Private label resistance (within protein): While private label exists across packaged nutrition, branded products typically benefit from perceived formulation consistency, taste/texture differentiation, and established consumer routines around specific product types (RTD vs. powder vs. bar). This raises the share of demand that can be defended without matching all retailer pricing pressure.
  • Cost and sourcing competence: Protein ingredients are commodity-linked. Operational procurement and manufacturing know-how help sustain gross margin through input volatility.
Competitive benchmarking (primary rivals):
  • Abbott Laboratories (nutrition and medical-adjacent brands): focuses more heavily on clinically positioned nutrition and diabetes management use cases, with overlap in convenience nutrition but a different category center of gravity.
  • Nestlé (powders and meal-replacement nutrition): emphasizes large-scale global nutrition portfolios; competition includes convenience nutrition and dietary supplementation.
  • Glanbia (Optimum Nutrition/MyProtein ecosystem): strong in sports nutrition and performance powders, typically competing more directly on the workout/athlete end of the protein spectrum.
BellRing vs. these rivals: BellRing’s emphasis is on mainstream protein fulfillment—RTD beverages and consumer-friendly protein formats—where retail distribution execution and brand/package-market fit are decisive. Rivals with heavier medical nutrition exposure or a larger global mix often compete through different consumer segments and merchandising strategies.

🚀 Multi-Year Growth Drivers

BellRing’s multi-year opportunity is anchored in enduring category tailwinds that expand the total number of protein occasions:
  • Higher protein consumption as a lifestyle norm: Convenience protein products align with ongoing shifts toward fitness, satiety, and meal supplementation.
  • Repeatable consumption habits: RTD and snackable formats support routine purchasing, strengthening SKU-level demand when retailers maintain distribution and adequate inventory.
  • Innovation-led SKU expansion: Flavor, ingredient, texture, and formulation refinement can open incremental market share within the protein shelf—especially when packaged nutrition consumers trade up from commodity propositions.
  • Channel breadth and capacity to scale: Grocery, club, mass, and e-commerce each reward different merchandising mechanics; scale helps fund the testing and rollout of winning formats.
Over a 5–10 year horizon, BellRing’s TAM is best viewed as the growing addressable market for convenient, protein-forward nutrition—where share gains are achievable through sustained retailer execution and brand/product-market fit, rather than reliance on a single product cycle.

⚠ Risk Factors to Monitor

Key structural and operational threats include:
  • Ingredient cost volatility: Protein ingredients and related input categories can pressure gross margin without sufficient pricing power or hedging/contracting flexibility.
  • Retailer promotion intensity and private label pressure: Large retailers can increase promotional cadence or expand house brands, compressing realized pricing and forcing trade-off decisions between volume and margin.
  • Demand normalization risk for discretionary nutrition: If consumer spending shifts away from premium protein formats, velocity and inventory management can deteriorate.
  • Quality/regulatory exposure: As an FDA-regulated food supplement/manufactured nutrition business, labeling compliance, adverse event reporting, and product quality systems remain critical.
  • Concentration in major customers: Retailer purchasing power can influence terms, slotting/allowances, and forecasting discipline.

📊 Valuation & Market View

The market generally values branded consumer nutrition businesses using EV/EBITDA and P/S frameworks, with attention to the quality of earnings drivers:
  • Gross margin sustainability (ingredient/input pass-through capability and mix)
  • Net revenue growth driven by volume and SKU mix rather than only price
  • Operating leverage from scale in procurement, manufacturing efficiency, and overhead absorption
  • Trade spend efficiency: the ability to grow share without permanently impairing margins
Multiple expansion tends to be supported by durable category share gains, stable gross margin through input cycles, and credible management of retailer economics.

🔍 Investment Takeaway

BellRing Brands presents an evergreen investment profile as a scaled branded player in mainstream protein nutrition. The core advantage is a distribution-anchored, scale-driven moat—supported by procurement and execution capabilities—that can defend share through periods of retailer pressure and input volatility. The long-term thesis rests on ongoing category growth in convenient protein consumption and the company’s ability to translate brand/product-market fit into durable retailer velocity, while maintaining gross margin discipline and trade spend effectiveness.

⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for BRBR.

247wallst.com2026-06-03

5 Stocks Set to Cash in on The Next 90-Million Customer Industry. (It's Not AI)

Wells Fargo's chief agriculture economist Dr. Michael Swanson told Bloomberg Businessweek on May 29 that GLP-1 weight-loss drugs (Ozempic, Wegovy, Mounjaro, Zepbound) will eventually match statins at roughly 90 million prescriptions, calling the trend “here to stay” because it's prescribed, not faddish.

benzinga.com2026-05-06

These Analysts Lower Their Forecasts On BellRing Brands After Downbeat Q2 Results

BellRing Brands (NYSE:BRBR) on Tuesday reported worse-than-expected second-quarter financial results and cut its FY26 sales guidance below estimates.

prnewswire.com2026-05-05

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against BellRing Brands, Inc.

MILWAUKEE, May 5, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against BellRing (NYSE: BRBR). The investigation results from inaccurate statements BellRing may have made regarding its financial statements, business operations and prospects.

marketwatch.com2026-05-05

Cheaper protein shakes are crushing this industry stalwart

Shares of BellRing Brands, the maker of Premier Protein drinks and PowerBar snacks, are tumbling more than 40%.

fool.com2026-05-05

Why BellRing Brands Stock Plunged 47% Today

Why did BellRing Brands lose nearly half its value in one morning? Protein shake competition and margin pressure are taking a toll.

seekingalpha.com2026-05-05

BellRing Brands, Inc. (BRBR) Q2 2026 Earnings Call Transcript

BellRing Brands, Inc. (BRBR) Q2 2026 Earnings Call Transcript

barrons.com2026-05-05

BellRing Stock Plunges 44% After Earnings Miss, Revised Outlook

Sales volume increased, but consumers have been trading down to lower-priced products or only buying when there is a discount.

zacks.com2026-05-05

BellRing Brands (BRBR) Lags Q2 Earnings and Revenue Estimates

BellRing Brands (BRBR) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.53 per share a year ago.

globenewswire.com2026-05-05

BellRing Brands Reports Results for the Second Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook

ST. LOUIS, May 05, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global proactive wellness category, today reported results for the second fiscal quarter ended March 31, 2026.

zacks.com2026-04-30

BellRing Brands (BRBR) Rises Higher Than Market: Key Facts

BellRing Brands (BRBR) closed at $17.8 in the latest trading session, marking a +1.48% move from the prior day.

globenewswire.com2026-04-29

Kuehn Law Encourages Investors of BellRing Brands, Inc. to Contact Law Firm

NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of BellRing Brands, Inc. (NYSE: BRBR) breached their fiduciary duties to shareholders.

zacks.com2026-04-29

Kraft Heinz (KHC) Expected to Beat Earnings Estimates: Should You Buy?

Kraft Heinz (KHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com2026-04-28

Earnings Preview: BellRing Brands (BRBR) Q2 Earnings Expected to Decline

BellRing Brands (BRBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

globenewswire.com2026-04-20

Attention Long-Term Shareholders of BellRing Brands, Inc. (NYSE: BRBR); Coty Inc. (NYSE: COTY); e.l.f. Beauty, Inc. (NYSE: ELF); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, April 20, 2026 (GLOBE NEWSWIRE) -- BELLRING BRANDS, INC. (NYSE: BRBR): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of BellRing Brands, Inc. (NYSE: BRBR). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

newsfilecorp.com2026-04-20

Kuehn Law Encourages Investors of BellRing Brands, Inc. to Contact Law Firm

New York, New York--(Newsfile Corp. - April 20, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of BellRing Brands, Inc . (NYSE: BRBR) breached their fiduciary duties to shareholders.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"BRBR reported Q2 2026 revenue of $598.7M and net income of -$43.7M (EPS $0.29, diluted $0.29). Year-over-year, revenue fell from $588.0M in Q2 2025 to $598.7M in Q2 2026 (+1.9% YoY), while net income swung from +$58.7M to -$43.7M (down ~174.5% YoY). Sequentially, revenue rose from $537.3M in Q1 2026 (+11.4% QoQ) but net income deteriorated from +$43.7M to -$43.7M (down ~200% QoQ). Profitability contracted sharply: gross margin declined to 27.4% from 29.5% (QoQ) and 32.3% (YoY), and net margin turned negative at -7.3% (vs +8.1% in Q1 2026 and +10.0% in Q2 2025). Cash flow weakened materially: operating cash flow was -$11.2M and free cash flow was +$7.3M, contrasting with positive operating cash flow in the prior quarter (-$3.1M in Q1 2026). Balance sheet risk remains elevated with total equity still negative (-$497.8M), while long-term debt is ~$1.185B; cash was $32.6M and net debt ~ $1.152B. Total shareholder return looks pressured: the stock is down 78.2% over 1 year and shows no dividend support. Price targets (consensus $32.1) imply a large upside versus ~$16.14, but near-term fundamentals are deteriorating."

Revenue Growth

Caution

Revenue increased 11.4% QoQ (from $537.3M to $598.7M) but was only up 1.9% YoY (from $588.0M). Growth is not strong enough to offset profitability deterioration.

Profitability

Neutral

Net income dropped from +$43.7M in Q1 2026 to -$43.7M in Q2 2026 (~-200% QoQ) and from +$58.7M YoY to -$43.7M (down ~174.5% YoY). Net margin fell to -7.3% from +8.1% QoQ and +10.0% YoY; gross margin also declined (27.4% vs 29.5% QoQ).

Cash Flow Quality

Neutral

Operating cash flow turned negative to -$11.2M in Q2 2026 (down from -$3.1M in Q1 2026). Free cash flow stayed positive (+$7.3M), but the earnings-to-cash profile is weakening.

Leverage & Balance Sheet

Neutral

Equity remains deeply negative (-$497.8M) with total assets ~$1.03B. Long-term debt is large (~$1.185B) and net debt remains very high (~$1.152B). Liquidity is limited with cash of ~$32.6M.

Shareholder Returns

Neutral

Stock performance is strongly negative (1Y -78.17%, 6M -51.40%, YTD -38.14%). No dividend yield is indicated, and cash/buyback activity does not compensate for the price decline in total return terms.

Analyst Sentiment & Valuation

Fair

Consensus price target ($32.1) is materially above the current ~$16.14, suggesting valuation upside if turnaround occurs. However, the near-term earnings trend is unfavorable.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

BRBR’s Q2 FY26 results missed expectations, with adjusted EBITDA margin at 9%—400 bps below guide—primarily from a $11m inventory-related charge (190 bps) plus unfavorable price/mix tied to higher promotional lifts and higher freight/protein costs. Net sales grew only 2% to $599m, with Premier RTD up modestly (+2.3%) but at the cost of reduced baseline velocities as consumers became more promo- and value-driven (27% of RTD volumes sold on price promotion, +8 pts YoY). Management reset full-year guidance to flat-to-up 2% net sales and ~14% adjusted EBITDA margin (including 50 bps from the Q2 charge), cutting 2H sales growth to +1% (vs +8% implied previously). The company remains committed to defending share via promotion and advertising (~4% of sales), while launching two Q4 innovations (Ultimate 42g and sparkling soda) to drive trial. Overall, outlook is pressured by freight and protein inflation ramping from Q3 into Q4 and continued competitive intensity—especially in club.

AI IconGrowth Catalysts

  • Premier Protein coffee health innovation promotion with extensive displays/end caps drove record quarter sales and consumption and meaningful household gains (including new-to-category)
  • Plan to repeat the large-mass retailer promotion in Q4 to drive trial and penetration
  • Advertising creative “go get ’em” launched late December showed early ROI signals (awareness/brand equity/traffic) and is expected to be maintained at ~4% of sales
  • Innovation pipeline: Premier Protein Ultimate (42g shake) and Premier Protein sparkling soda (15g protein, 5-ingredient label; 4 fruit flavors) launching in Q4 into mass/e-commerce/select FDM

Business Development

  • Named partners were not specified; management referenced a “club retailer” and a “large mass retailer” whose Q2 promotions produced record quarter sales/consumption and household gains
  • Innovation expected distribution through mass, e-commerce, and select food retailers (Premier Protein Ultimate) and “a significant mass retailer” plus e-commerce and many FDM retailers (Premier Protein sparkling soda)

AI IconFinancial Highlights

  • Q2 net sales: $599m, +2% YoY but “modestly below” expectations; Premier Protein net sales +1.7% (RTD shake +2.3%) while Dymatize -2%
  • Adjusted EBITDA margin: 9% in Q2, down 400 bps vs guide (13%); inventory-related charge: $11m contributing 190 bps of the miss
  • Gross margin: adjusted gross margin 22.7% vs 34.5% prior year, driven by input inflation (including tariffs), unfavorable price/mix, higher freight, and the inventory charge
  • Advertising investment increased 140 bps as a % of sales in Q2
  • Full-year outlook reset: net sales $2.325b–$2.365b (flat to +2%); adjusted EBITDA margin expected ~14% including 50 bps impact from the Q2 inventory-related charge
  • Second-half sales growth cut to +1% vs prior guide implying +8%, largely from reduced Premier RTD shake baseline velocity in Q3 and mix dynamics in Q4
  • Margin bridge for 2H: higher freight & protein costs ~200 bps; unfavorable mix & increased trade investment ~160 bps; lower cost savings/manufacturing ~60 bps; remaining decline from lower SG&A leverage

AI IconCapital Funding

  • Share repurchases: $26m in Q2
  • Liquidity/leverage: ended quarter with net leverage of 3x; expects leverage to remain in the low 3s through FY26 (also referencing a legal settlement payment expected in Q4)
  • Guidance framing: expects strong cash flow generation in 2H consistent with historical conversion

AI IconStrategy & Ops

  • Promotions: Q2 events ran as communicated in early February with no further events added; however, promo intensity rose (RTD shake category price promotion volume = 27% of volumes, +8 percentage points YoY)
  • Demand/velocity pattern: consumption softer in promoted vs non-promoted weeks; mix shift toward promoted volume driven by increased competitive lifts and consumer trade-down
  • Distribution: management reiterated on-track double-digit TDP growth in 2026 with single-serve bottles supporting trial/display strategy
  • Operational cost/cadence: acknowledged freight acceleration from geopolitical/oil impacts (Middle East conflict) and protein input inflation ramp late in the quarter (late March/April)

AI IconMarket Outlook

  • Q3 net sales growth expected down ~1%; Q3 adjusted EBITDA margin expected ~16%
  • FY26 net sales expected flat to +2% (implies +1% in 2H vs earlier +8% implied); Q4 expected additional promotional activity that increases trade spend and unfavorably impacts mix
  • Protein input inflation expected to begin impacting in Q3 with greater impact in Q4 (per management commentary)
  • Long-term algorithm reassessment planned in November (stated by management)

AI IconRisks & Headwinds

  • Competition intensified: category promotional frequency and breadth rose sharply YoY; new/smaller entrants investing aggressively increased cost to defend share
  • Consumer price sensitivity/trade-down: RTD shake spend per household contracted (first decline in 5 years per management), and higher response to promoted price pressured non-promoted baselines
  • Input-cost inflation: protein-driven commodity inflation above expectations; tariffs and higher freight costs; freight elevated due to Middle East conflict; nonfat dry milk market on CME increased significantly
  • Inventory-related charge: $11m inventory-related charge discovered late March, contributing 190 bps variance in Q2
  • Channel mix risk: club channel challenged in Q3 due to higher promotional intensity and consumer trade-down

Q&A: Analyst Interest

  • Pricing power credibility: Management said pricing power remains intact due to Premier’s high repeat/loyalty and history of taking “3 or 4” price increases over five years while still growing, supported by assumed elasticities and the belief that affordability constraints are largely transitory despite current competitive/promo intensity.
  • Inflation timing + magnitude: Management linked freight acceleration to the Middle East conflict (post-February, beyond), and whey protein and nonfat dry milk increases as the larger driver in 2H. They said the biggest new news is nonfat dry milk rising sharply; coverage was largely achieved for FY26, with potential 2027 headwinds if levels persist.
  • Which channels face pressure + when started: Management clarified that the new data since February mattered because club/mass promotions had not fully occurred. They stated increased price sensitivity hits across channels but is “most acute in club,” driven by the highest promo list and baseline pressure, with competitive intensity starting in February.

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the BRBR Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for BRBR.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (BRBR)

© 2026 Stock Market Info — BellRing Brands, Inc. (BRBR) Financial Profile